A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma

A four‐factor immune risk score signature predicts the clinical outcome of patients with spinal chordoma

Abstract Background Currently, the measurement of immune cells in previous studies is usually subjective, and no immune‐based prognostic model has been established for chordoma. In this study, we sought to simultaneously measure tumor‐infiltrating lymphocyte (TIL) subtypes in chordoma samples using...

Full description

Bibliographic Details
Main Authors: Ming‐Xiang Zou, Yue Pan, Wei Huang, Tao‐Lan Zhang, David Escobar, Xiao‐Bin Wang, Yi Jiang, Xiao‐Ling She, Guo‐Hua Lv, Jing Li
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Clinical and Translational Medicine
Subjects:
immune risk score
multiplex immunofluorescence
nomogram
spinal chordoma
tumor‐infiltrating lymphocytes
Online Access:https://doi.org/10.1002/ctm2.4

Internet

https://doi.org/10.1002/ctm2.4

Similar Items